For citations:
Mazurov VI, Belyaeva IB, Samigullina RR, Chudinov AL, Dadalova AM. Pathogenetic significance of the use of a humanized monoclonal antibody to the IL-6-α receptor (tocilizumab) in the treatment of immuno-inflammatory diseases. Meditsinskiy sovet = Medical Council. 2020;(8):102-112. (In Russ.) https://doi.org/10.21518/2079-701X-2020-8-102-112